Page last updated: 2024-08-23

pravastatin and Nephrotic Syndrome

pravastatin has been researched along with Nephrotic Syndrome in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (70.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, YW; Cheng, HT; Liao, MT; Lin, WC; Lin, YH; Tsai, IJ; Tsau, YK	1
Aihara, Y; Harada, T; Inaba, A; Ito, S; Machida, H; Nakamura, T; Okuyama, K; Yokota, S	1
Muso, E; Sasayama, S; Shio, H; Yashiro, M	1
Cattran, D; Porush, JG; Spitalewitz, S; Wright, N	1
Hattori, M; Ito, K; Kawaguchi, H; Khono, M; Kubota, R; Tanaka, T	1
Balletta, M; Bellinghieri, G; Bovino, M; Cianciaruso, B; Colucci, G; Conte, G; Dal Canton, A; Esposito, C; Fuiano, G; Rosa, M; Sepe, V	1
Li, J; Lu, Y; Zheng, X	1
Ando, T; Arisaka, O; Hoshi, E; Ito, S; Kano, K; Kyo, K; Tomita, S; Ueda, Y; Yamada, Y	1
Furuta, S; Higuchi, M; Hora, K; Miyasaka, M; Oguchi, H; Terashima, M; Tokoo, M; Tokunaga, S; Yoshie, T	1
Kurota, M; Maeda, H; Matsuda, T; Miyaho, S; Morikawa, K; Nakai, T; Oida, K; Takahashi, S; Takai, H; Tamai, T	1

Reviews

1 review(s) available for pravastatin and Nephrotic Syndrome

Article	Year
Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 22, Issue:1 Topics: Adult; Aged; Cholesterol; Double-Blind Method; Humans; Hyperlipidemias; Middle Aged; Nephrotic Syndrome; Pravastatin; Prospective Studies	1993

Trials

3 trial(s) available for pravastatin and Nephrotic Syndrome

Article	Year
Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 22, Issue:1 Topics: Adult; Aged; Cholesterol; Double-Blind Method; Humans; Hyperlipidemias; Middle Aged; Nephrotic Syndrome; Pravastatin; Prospective Studies	1993
Effects of hypercholesterolemia of renal hemodynamics: study in patients with nephrotic syndrome. Nephron, 1996, Volume: 73, Issue:3 Topics: Adult; Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Inulin; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; p-Aminohippuric Acid; Pravastatin; Proteinuria; Renal Circulation; Single-Blind Method	1996
Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome. Nihon Jinzo Gakkai shi, 1992, Volume: 34, Issue:4 Topics: Adult; Aged; Apolipoproteins; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Nephrotic Syndrome; Pravastatin	1992

Other Studies

7 other study(ies) available for pravastatin and Nephrotic Syndrome

Article	Year
A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy. Clinical nephrology, 2012, Volume: 78, Issue:3 Topics: Age of Onset; Anti-Inflammatory Agents; Antihypertensive Agents; Apolipoprotein E2; Child; Enalapril; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methylprednisolone; Mutation; Nephrotic Syndrome; Pravastatin	2012
Amelioration of steroids and cyclosporine-resistant nephrotic syndrome by pravastatin. Pediatric nephrology (Berlin, Germany), 2007, Volume: 22, Issue:4 Topics: Adolescent; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Pravastatin; Remission Induction; Steroids	2007
Amelioration of hypercholesterolaemia by HMG-CoA reductase inhibitor (Pravastatin) improved platelet hyperaggregability in nephrotic patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:12 Topics: Humans; Hypercholesterolemia; Nephrotic Syndrome; Platelet Aggregation; Pravastatin; Serum Albumin; Thromboxane B2	1994
Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis. Pediatric nephrology (Berlin, Germany), 1993, Volume: 7, Issue:2 Topics: Adolescent; Blood Component Removal; Combined Modality Therapy; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Function Tests; Lipoproteins, LDL; Male; Nephrotic Syndrome; Pravastatin	1993
[Lipid-lowering effect of pravastatin on glomerulosclerosis protection and treatment]. Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:4 Topics: Animals; Anticholesteremic Agents; Cholesterol; Glomerulosclerosis, Focal Segmental; Male; Nephrotic Syndrome; Pravastatin; Puromycin; Rats; Rats, Sprague-Dawley; Triglycerides	1997
Effects of combination therapy consisting of moderate-dose intravenous immunoglobulin G, pulsed methylprednisolone and pravastatin in children with steroid-resistant nephrosis. Nephron, 2000, Volume: 84, Issue:1 Topics: Anticholesteremic Agents; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Nephrotic Syndrome; Pravastatin	2000
[A case of familial hypercholesterolemia associated with nephrotic syndrome]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Aug-10, Volume: 79, Issue:8 Topics: Cholestyramine Resin; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Middle Aged; Naphthalenes; Nephrotic Syndrome; Pravastatin; Prednisolone; Probucol	1990